In contrast, while GFR adjusted levels were generally lower in both groups, GFR-adjusted hs-cTnT was instead higher among CKD-T patients than for CKD patients (median 2.5 vs. 1.6 ng/L; p = 0.001), while GFR-adjusted NT-proBNP levels were similar in the two patient groups (p = 0.47). The gene discussed is TNNT2; the disease is chronic kidney disease.